company background image
CYC

Cyclopharm ASX:CYC Stock Report

Last Price

AU$1.35

Market Cap

AU$125.6m

7D

3.8%

1Y

-18.7%

Updated

07 Dec, 2022

Data

Company Financials +
CYC fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

CYC Stock Overview

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally.

Cyclopharm Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cyclopharm
Historical stock prices
Current Share PriceAU$1.35
52 Week HighAU$1.95
52 Week LowAU$0.95
Beta0.62
1 Month Change7.14%
3 Month Change-12.90%
1 Year Change-18.68%
3 Year Change28.57%
5 Year Change51.69%
Change since IPO-28.00%

Recent News & Updates

Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Oct 17
Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Recent updates

Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Oct 17
Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Jun 09
Companies Like Cyclopharm (ASX:CYC) Can Afford To Invest In Growth

Analyst Forecasts For Cyclopharm Limited (ASX:CYC) Are Surging Higher

Mar 06
Analyst Forecasts For Cyclopharm Limited (ASX:CYC) Are Surging Higher

Here's Why We're Not At All Concerned With Cyclopharm's (ASX:CYC) Cash Burn Situation

Mar 02
Here's Why We're Not At All Concerned With Cyclopharm's (ASX:CYC) Cash Burn Situation

We Think Cyclopharm (ASX:CYC) Can Afford To Drive Business Growth

Oct 22
We Think Cyclopharm (ASX:CYC) Can Afford To Drive Business Growth

Cyclopharm Limited's (ASX:CYC) Analyst Just Slashed This Year's Estimates

Jun 29
Cyclopharm Limited's (ASX:CYC) Analyst Just Slashed This Year's Estimates

Shareholders Will Probably Hold Off On Increasing Cyclopharm Limited's (ASX:CYC) CEO Compensation For The Time Being

Apr 27
Shareholders Will Probably Hold Off On Increasing Cyclopharm Limited's (ASX:CYC) CEO Compensation For The Time Being

Rainbows and Unicorns: The Cyclopharm Limited (ASX:CYC) Analyst Just Became A Lot More Optimistic

Mar 01
Rainbows and Unicorns: The Cyclopharm Limited (ASX:CYC) Analyst Just Became A Lot More Optimistic

Cyclopharm (ASX:CYC) Has Rewarded Shareholders With An Exceptional 401% Total Return On Their Investment

Feb 07
Cyclopharm (ASX:CYC) Has Rewarded Shareholders With An Exceptional 401% Total Return On Their Investment

Is Cyclopharm Limited (ASX:CYC) Popular Amongst Insiders?

Jan 02
Is Cyclopharm Limited (ASX:CYC) Popular Amongst Insiders?

We're Not Very Worried About Cyclopharm's (ASX:CYC) Cash Burn Rate

Dec 06
We're Not Very Worried About Cyclopharm's (ASX:CYC) Cash Burn Rate

Shareholder Returns

CYCAU Medical EquipmentAU Market
7D3.8%-1.0%-0.03%
1Y-18.7%-9.0%-4.1%

Return vs Industry: CYC underperformed the Australian Medical Equipment industry which returned -9% over the past year.

Return vs Market: CYC underperformed the Australian Market which returned -4.1% over the past year.

Price Volatility

Is CYC's price volatile compared to industry and market?
CYC volatility
CYC Average Weekly Movement8.8%
Medical Equipment Industry Average Movement10.1%
Market Average Movement8.9%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market4.1%

Stable Share Price: CYC is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: CYC's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
198651James McBrayerhttps://www.cyclopharm.com

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism.

Cyclopharm Limited Fundamentals Summary

How do Cyclopharm's earnings and revenue compare to its market cap?
CYC fundamental statistics
Market CapAU$125.62m
Earnings (TTM)-AU$3.68m
Revenue (TTM)AU$22.93m

5.5x

P/S Ratio

-34.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CYC income statement (TTM)
RevenueAU$22.93m
Cost of RevenueAU$6.36m
Gross ProfitAU$16.57m
Other ExpensesAU$20.25m
Earnings-AU$3.68m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.04
Gross Margin72.27%
Net Profit Margin-16.03%
Debt/Equity Ratio0%

How did CYC perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

-25%

Payout Ratio